Investment in Minnetronix

New York, NY: Altaris Capital Partners, LLC announces an investment in Minnetronix, Inc.
Minnetronix provides design, development and manufacturing services to the medical technology industry. The Company is also leveraging its engineering expertise to develop a platform of proprietary technologies that possess clinical breakthrough potential. Altaris is partnering with the Minnetronix management team and employees to support the future growth of the Company.
Altaris Capital Partners was advised on this transaction by Piper Jaffray and Schiff Hardin LLP.
About Altaris Capital Partners, LLC
Altaris Capital Partners, LLC is an investment firm focused exclusively on the healthcare industry. Managing $1.3 billion of equity capital, Altaris invests in businesses that meet clearly defined healthcare needs and leverages its extensive industry knowledge and relationships to accelerate growth and value appreciation. Altaris is based in New York, NY. www.altariscap.com
About Minnetronix, Inc.
Minnetronix is a medical technology and innovation company with deep expertise in electronic and electromechanical devices. Founded in 1996, the company creates new technologies and therapies that solve unmet clinical and business needs for patients and medical device companies. Minnetronix is FDA Registered and ISO 13485 Certified. www.minnetronix.com

CSafe Global Continues to Expand European Product Offering

Dayton, OH Jan 13, 2016 – CSafe Global, the only provider of a full-line of active and passive cold chain packaging solutions, will be exhibiting an approved CE compliant small active container and several temperature-management mobile couriers at the 15th Annual IQPC Temperature Controlled Logistics Europe event in Frankfurt on 26/27 Jan 2016.
The 2016 IQPC cold chain conference will be the European launch platform for a high-performance portable CE approved refrigerated/frozen container for transporting sensitive biologic, vaccine and blood products as well as an offering enhancement to the existing AcuTemp brand couriers. The company will be displaying their active, passive packaging and passive mobile handheld couriers at stand No. 27.
According to Brian Kohr, President and CEO at CSafe Global, “The success of these CSafe Global products over the past year has been exceptional as the market adjusts to new regulatory requirements and to the special transportation requirements of high-value, environmentally-sensitive, bio-pharmaceuticals. In addition, our successful pursuit of collaborative partnerships with key customers and suppliers has allowed us to steadily expand our reach into developing countries and new locations.
“Particularly we have seen pharma shippers increasingly adopt a ‘total cost of ownership’ approach where the true lifetime costs of cool chain solutions are taken into consideration. With our extensive range of both active and passive solutions, from full-size ULDs to smaller hand-portable units, and with a variety of buying and leasing options available, CSafe have been able to capitalise strongly on the growing emphasis on cost rather than price.”
CSafe Global invites pharmaceutical industry shippers and logistics specialists to IQPC Europe, January 26th and 27th, at the Frankfurt Messe, Booth 27.